General Information of the Compound
Compound ID |
CP0448556
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
(+/-)2-(2-Methoxy-phenyl)-1-methyl-ethylamine
Show/Hide
|
||||||||||||||||||
Synonyms |
(d,l)-2-Methoxyamphetamine
1-(2-METHOXYPHENYL)-2-PROPYLAMINE
1-(2-methoxyphenyl)propan-2-amine
15402-84-3
2-(2-Methoxy-phenyl)-1-methyl-ethylamine
2-Methoxy(phenylisopropyl)amine
2-Methoxyamphetamine
AC1L4MFB
AC1Q45CZ
AC1Q45D0
AC1Q57OA
AMBZ0414
Benzeneethanamine, 2-methoxy-alpha-methyl-
Benzeneethanamine,2-methoxy--methyl-
CHEMBL16451
Methoxyphenamine, N-desmethyl
N-Desmethylmethoxyphenamine
NDMP
SCHEMBL266563
o-Methoxy(phenylisopropyl)amine
o-Methoxy-a-methylphenethylamine
o-Methoxyamphetamine
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C10H15NO
|
||||||||||||||||||
Molecular Weight |
165.236
|
||||||||||||||||||
Canonical SMILES |
COc1ccccc1CC(C)N
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C10H15NO/c1-8(11)7-9-5-3-4-6-10(9)12-2/h3-6,8H,7,11H2,1-2H3
Show/Hide
|
||||||||||||||||||
InChIKey |
VBAHFEPKESUPDE-UHFFFAOYSA-N
|
||||||||||||||||||
CAS |
15402-84-3
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01492, 5-hydroxytryptamine receptor 2A
Protein ID: PT01480, 5-hydroxytryptamine receptor 2C
Clinical Information about the Compound